Home › Functietitels › Quality Control Chemist
Quality Control Chemist: H-1B-salarissen
149 arbeidsvoorwaardenaanvragen gebruikten de functietitel Quality Control Chemist. Mediaan aangeboden basissalaris $69.798; middenhelft $64.000–$83.460.
Aanvragen (LCA's)149
Mediaan aangeboden salaris$69.798
Middelste helft van salarissen$64.000–$83.460
10e–90e percentiel$62.000–$98.000
Immigratieadvocaat, recruiter of werkgever? Laat uw dienst bovenaan deze pagina zien — $99 voor 30 dagen →
Werkgevers
| Werkgever | LCAs | Mediaan salaris |
|---|
| Sciegen Pharmaceuticals Inc. | 28 | $73.700 |
| Ascent Pharmaceuticals, Inc. | 16 | $84.540 |
| Evaric Pharmaceuticals Inc. | 15 | $72.000 |
| Bactolac Pharmaceutical Inc. | 9 | $85.000 |
| APPCO Pharma LLC | 6 | $89.000 |
| Nature's Value Inc | 5 | $64.000 |
| Novitium Pharma LLC. | 4 | $81.798 |
| Winder Laboratories, LLC | 4 | $63.617 |
| Novel Laboratories, Inc. | 3 | $85.000 |
| AACE Pharmaceuticals Inc. | 3 | $66.000 |
| Granulation Technology, Inc. | 3 | $61.963 |
| Health Pharma USA LLC | 3 | $61.000 |
| AVA Inc. | 2 | $66.560 |
| Splint Pharma LLC | 2 | $71.292 |
| AARKISH Pharmaceuticals NJ, Inc. | 2 | $67.000 |
| Kanap Systems LLC | 2 | $94.775 |
| Internash Global Services, LLC | 2 | — |
| AmbioPharm, Inc. | 2 | $68.328 |
| Leading Pharma, LLC | 2 | $66.466 |
| Hubot, Inc. | 2 | $62.000 |
| BLI International Inc. | 2 | $63.658 |
| Seaway Pharma Inc | 2 | $64.397 |
| Kurepro, Inc. | 1 | $75.000 |
| Ajes Pharmaceuaticals, LLC | 1 | $61.963 |
| The Veritas Healthcare Solutions LLC | 1 | $80.184 |
| Jogue, Inc. | 1 | $54.080 |
| Belcher Pharmaceuticals, LLC | 1 | $82.118 |
| InvaGen Pharmaceuticals, Inc. | 1 | $66.331 |
| Prestonwood Home Healthcare LLC | 1 | $52.229 |
| Societal CDMO San Diego, LLC | 1 | $73.823 |
| The Lubrizol Corporation | 1 | $41.704 |
| Kobo Products, Inc. | 1 | $61.000 |
| Globex Healthcare & Pharma Inc. | 1 | $61.069 |
| Nucrogene Inc | 1 | $60.902 |
| Reliance Rubber Industries, Inc. | 1 | $74.422 |
| SMG Global Circuits, Inc. | 1 | $64.000 |
| Excelsior Nutrition Inc. | 1 | $54.080 |
| KVK-Tech, Inc. | 1 | $66.000 |
| Havix Group Inc. | 1 | $70.000 |
| Navinta III Inc. | 1 | $65.000 |
| Essential Industries, Inc. | 1 | $72.000 |
| Chromak Research, Inc. | 1 | $65.000 |
| Bioactive Services LLC | 1 | $65.000 |
| Ajenat Pharmaceuticals, LLC | 1 | $76.170 |
| Populus Group LLC | 1 | $55.598 |
| Epic Pharma LLC | 1 | $98.000 |
| Protech Powder Coatings Inc. | 1 | $65.062 |
| Accuon Labs Inc. | 1 | $66.300 |
| Cal Royal Products Inc. | 1 | — |
| SK Battery America, Inc. | 1 | $70.000 |
| IT Land LLC | 1 | $64.500 |
| Samjan Group Inc. | 1 | $80.974 |
Per loonniveau
| Loonniveau | Mediaan salaris |
|---|
| Niveau I (instap) | $64.750 |
| Niveau II (gekwalificeerd) | $85.000 |
| Niveau III (ervaren) | $99.438 |
| Niveau IV (volledig bekwaam) | $108.559 |
Het Department of Labor stelt vier heersende loonniveaus vast voor elk beroep en gebied, van Niveau I (instap) tot Niveau IV (volledig bekwaam). De werkgever kiest het niveau dat bij de vereisten van de baan past.
Per boekjaar
| Boekjaar | LCAs | Mediaan salaris |
|---|
| FY2023 | 37 | $72.000 |
| FY2024 | 35 | $80.000 |
| FY2025 | 41 | $64.397 |
| FY2026 | 29 | $70.000 |
Steden
- Hauppauge, NY52
- Central Islip, NY16
- Fairfield, NJ11
- Piscataway, NJ7
- Coram, NY5
- East Windsor, NJ4
- Winder, GA4
- Somerset, NJ3
- Rahway, NJ3
- Willowbrook, IL2
- Largo, FL2
- South Plainfield, NJ2
- Cambridge, MA2
- Houston, TX2
- Beech Island, SC2
- South Bend, IN2
- Deer Park, NY2
- Massena, NY2
- City of Industry, CA1
- Copiague, NY1
- Thousand Oaks, CA1
- New York, NY1
- Northville, MI1
- Fall River, MA1
- Grand Prairie, TX1
- San Diego, CA1
- Bowling Green, OH1
- Salt Lake City, UT1
- Branchburg, NJ1
- Westland, MI1
Salarissen zijn het laagste eind van het aangeboden loon per aanvraag, omgerekend naar een jaarbedrag; statistieken gebruiken alleen gecertificeerde fulltime aanvragen. Een LCA is geen visumgoedkeuring en één LCA kan meerdere functies dekken. Bron: U.S. Department of Labor, OFLC LCA Disclosure Data, boekjaren 2023–2026 (laatste beslissing 30 jun. 2026).